Siemens plans public listing for its $15 billion healthcare division

In a move it claims to strengthen its brand, Siemens AG announced its plan to publicly list its $15 billion healthcare division, Siemens Healthineers. 

"Healthcare technology is a highly attractive business in which we want to further expand our leading position. With this step, we continue to implement Vision 2020 launched in May 2014. The public listing will give Healthineers even more focus and flexibility in pursuing its growth strategy," said Joe Kaeser, President and CEO of Siemens AG. 

Siemens Healthineers began operating in May of this year with a vision for Siemens AG to adjust to transformations in the healthcare market in a flexible and focused manner with its own market presence. Since its start, Siemens healthcare business has already seen an upward trend in its market share and developed an outstanding portfolio. 

The company will announce its planned date as soon as details are finalized, which will also depend on the stock market environment amongst other things.  

"Greater entrepreneurial freedom and agility will allow us to help shape the development of the global healthcare market and the growth strategies of successful healthcare providers. We'll enable our customers to participate successfully in the trends toward consolidation, industrialization and holistic health management with a high degree of clinical relevance, efficient workflows and financial value added,” said Bernd Montag, CEO of Siemens Healthineers. 

In fiscal year 2016, which ended Sept. 30, Siemens generated revenue of $86.7 billion and net income of $6.1 billion. At the end of September, the company had approximately 351,000 employees worldwide.

Jodelle joined TriMed Media Group in 2016 as a senior writer, focusing on content for Radiology Business and Health Imaging. After receiving her master's from DePaul University, she worked as a news reporter and communications specialist.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.